P143 - Postoperative recurrence factors in patients with pT3N0M0 clear cell renal cell carcinoma, called the M0 intermediate-high-risk group of the KEYNOTE 564 trial

Autor: Naito, H., Homare, O., Ryou, I., Tomoko, H., Yu, O., Yohei, A., Yoichiro, T., Yuki, M., Takuma, K., Rikiya, T., Nobufumi, U., Reiji, H., Mikio, S.
Zdroj: In European Urology March 2024 85 Supplement 1:S202-S202
Databáze: ScienceDirect